IMPACT OF MAJOR PRICE REDUCTION BY GOVERNMENT OF INDIA FOR DRUG ELUTING STENTS ON STENT TYPE IMPLANTATION AND ASSOCIATED OUTCOMES

Methods Ambirectional data of percutaneous coronary intervention (PCI) patients implanted with US FDA approved stents in India before(n1=1015) and after (n2=1059) pricing policy (March-August 2016 and 2017 respectively) were collected. Results With similar baseline characteristics(propensity score=0...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A210-A210
Main Authors: Bhatt, Parloop, Parikh, Parth, Chandarana, Anish, Chag, Milan, Kapoor, Vipul, Nanavati, Aditi, Patel, Tejas, Gupta, Satya, Baxi, Hemang, Shah, Urmil, Sankhla, Vineet, Jain, Neil, Parikh, Keyur
Format: Article
Language:English
Subjects:
Cardiology
Drug delivery
Implantation
Implants
Prices
Pricing policies
Stents
Surgical implants
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods Ambirectional data of percutaneous coronary intervention (PCI) patients implanted with US FDA approved stents in India before(n1=1015) and after (n2=1059) pricing policy (March-August 2016 and 2017 respectively) were collected. Results With similar baseline characteristics(propensity score=0.9) in both groups, newer pricing policy lead to reduction in stent prices without affecting PCI(before n1=738; after n2=775)and stent volumes(p=0.9).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)30751-4